Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression

References

• Davis ME. 2018. Epidemiology and overview of gliomas. Semin Oncol Nurs. 34(5):420–429. doi:10.1016/j.soncn.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Rasmussen BK, Hansen S, Laursen RJ, Kosteljanetz M, Schultz H, Norgard BM, Guldberg R, Gradel KO. 2017. Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the danish neuro-oncology registry. J Neurooncol. 135(3):571–579. doi:10.1007/s11060-017-2607-5.
   PubMed Web of Science ®Google Scholar
• Bielecka J, Markiewicz-Zukowska R. 2020. The influence of nutritional and lifestyle factors on glioma incidence. Nutrients. 12(6):1812. doi:10.3390/nu12061812.
   PubMed Web of Science ®Google Scholar
• Miller JJ, Wen PY. 2016. Emerging targeted therapies for glioma. Expert Opin Emerg Drugs. 21(4):441–452. doi:10.1080/14728214.2016.1257609.
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Wang P, Liu Q, Zheng H. 2017. Current status and future perspectives of sonodynamic therapy in glioma treatment. Ultrason Sonochem. 37:592–599. doi:10.1016/j.ultsonch.2017.02.020.
   PubMed Web of Science ®Google Scholar
• Kanapathipillai M. 2018. Treating p53 mutant aggregation-associated cancer. Cancers (Basel). 10(6):154. doi:10.3390/cancers10060154.
   PubMed Web of Science ®Google Scholar
• Whibley C, Pharoah PD, Hollstein M. 2009. p53 polymorphisms: cancer implications. Nat Rev Cancer. 9(2):95–107. doi:10.1038/nrc2584.
   PubMed Web of Science ®Google Scholar
• Jin Y, Xiao W, Song T, Feng G, Expression DZ. 2016. Prognostic significance of p53 in glioma patients: a meta-analysis. Neurochem Res. 41(7):1723–1731. doi:10.1007/s11064-016-1888-y.
   PubMed Web of Science ®Google Scholar
• Zhao QS, Ying JB, Jing JJ, Wang SS. 2020. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53. Eur Rev Med Pharmacol Sci. 24(8):4382–4388. doi:10.26355/eurrev_202004_21019.
   PubMed Web of Science ®Google Scholar
• Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. 2012. p53-Dependent induction of PVT1 and miR-1204. J Biol Chem. 287(4):2509–2519. doi:10.1074/jbc.M111.322875.
   PubMed Web of Science ®Google Scholar
• Derderian C, Orunmuyi AT, Olapade-Olaopa EO, Ogunwobi OO. 2019. PVT1 signaling is a mediator of cancer progression. Front Oncol. 9:502. doi:10.3389/fonc.2019.00502.
   PubMed Web of Science ®Google Scholar
• Han Y, Li X, He F, Yan J, Ma C, Zheng X, Zhang J, Zhang D, Meng C, Zhang Z, et al. 2019. Knockdown of lncRNA PVT1 inhibits glioma progression by regulating miR-424 expression. Oncol Res. 27(6):681–690. doi:10.3727/096504018X15424939990246.
   PubMed Web of Science ®Google Scholar
• Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. 2018. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of MiR-128-3p/GREM1 Axis and BMP signaling pathway. Neurotherapeutics. 15(4):1139–1157. doi:10.1007/s13311-018-0649-9.
   PubMed Web of Science ®Google Scholar
• Dahai Z, Daliang C, Famu L, Xiang W, Lenian L, Jianmin C, Xiaobing X. 2020. Lowly expressed lncRNA PVT1 suppresses proliferation and advances apoptosis of glioma cells through up-regulating microRNA-128-1-5p and inhibiting PTBP1. Brain Res Bull. 163:1–13. doi:10.1016/j.brainresbull.2020.06.006.
   PubMed Web of Science ®Google Scholar
• Shao Y, Chen HT, Ma QR, Zhang YW, He YQ, Liu J. 2020. Long non-coding RNA PVT1 regulates glioma proliferation, invasion, and aerobic glycolysis via miR-140-5p. Eur Rev Med Pharmacol Sci. 24(1):274–283. doi:10.26355/eurrev_202001_19922.
   PubMed Web of Science ®Google Scholar
• Shao Y, Chen HT, Ma QR, Zhang YW, He YQ, Liu J. 2020. Long non-coding RNA PVT1 regulates glioma proliferation, invasion, and aerobic glycolysis via miR-140-5p. Eur Rev Med Pharmacol Sci. 24(16):8249. doi:10.26355/eurrev_202008_22590.
   PubMedGoogle Scholar
• Zhang X, Feng W, Zhang J, Ge L, Zhang Y, Jiang X, Peng W, Wang D, Gong A, Xu M. 2018. Long noncoding RNA PVT1 promotes epithelialmesenchymal transition via the TGFbeta/Smad pathway in pancreatic cancer cells. Oncol Rep. 40(2):1093–1102. doi:10.3892/or.2018.6462.
   PubMed Web of Science ®Google Scholar
• Guan F, Kang Z, Wang L, Wang K, Mao BB, Peng WC, Zhang BL, Lin ZY, Zhang JT, Hu ZQ. 2019. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-beta/SMAD signaling pathway. Chin Med J (Engl). 132(20):2430–2437. doi:10.1097/CM9.0000000000000478.
   PubMed Web of Science ®Google Scholar
• Tao S, Liu M, Shen D, Zhang W, Wang T, Bai Y. 2018. TGF-beta/Smads signaling affects radiation response and prolongs survival by regulating DNA repair genes in malignant glioma. DNA Cell Biol. 37(11):909–916. doi:10.1089/dna.2018.4310.
   PubMed Web of Science ®Google Scholar
• Bourdon JC. 2007. p53 and its isoforms in cancer. Br J Cancer. 97(3):277–282. doi:10.1038/sj.bjc.6603886.
   PubMed Web of Science ®Google Scholar
• Yu BX, Zou L, Li S, Du YL. 2019. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma. Eur Rev Med Pharmacol Sci. 23(19):8456–8467. doi:10.26355/eurrev_201910_19158.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang X, Wu Z, Hu D, Jia J, Guo J, Tang T, Yao J, Liu H, Tang H. 2020. Long Noncoding RNA LINC00467 promotes glioma progression through inhibiting P53 expression via binding to DNMT1. J Cancer. 11(10):2935–2944. doi:10.7150/jca.41942.
   PubMed Web of Science ®Google Scholar
• Zhen ZG, Ren SH, Ji HM, Ma JH, Ding XM, Feng FQ, Chen SL, Zou P, Ren JR, Jia L. 2017. Linarin suppresses glioma through inhibition of NF-kappaB/p65 and up-regulating p53 expression in vitro and in vivo. Biomed Pharmacother. 95:363–374. doi:10.1016/j.biopha.2017.08.023.
   PubMed Web of Science ®Google Scholar
• Xiong X, Yuan J, Zhang N, Zheng Y, Liu J, Yang M. 2020. Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis. Biochem Biophys Res Commun. 521(2):478–484. doi:10.1016/j.bbrc.2019.10.137.
   PubMed Web of Science ®Google Scholar
• Pan X, Zheng G, Gao C. 2018. LncRNA PVT1: a novel therapeutic target for cancers. Clin Lab. 64(5):655–662. doi:10.7754/Clin.Lab.2018.171216.
   PubMed Web of Science ®Google Scholar
• Fang J, Huang J. 2019. Clinical significance of the expression of long non-coding RNA PVT1 in glioma. Cancer Biomark. 24(4):509–513. doi:10.3233/CBM-182253.
   PubMed Web of Science ®Google Scholar
• Zou H, Wu LX, Yang Y, Li S, Mei Y, Liu YB, Zhang L, Cheng Y, Zhou HH. 2017. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients. Oncotarget. 8(45):78767–78780. doi:10.18632/oncotarget.20226.
   PubMedGoogle Scholar
• Yang A, Wang H, Yang X. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2. Biosci Rep. 2017;37(6). doi:10.1042/BSR20170871.
   Google Scholar
• Kaminska B, Cyranowski S. 2020. Recent advances in understanding mechanisms of TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol. 1202:179–201. doi:10.1007/978-3-030-30651-9_9.
   PubMed Web of Science ®Google Scholar
• Sferra R, Pompili S, Festuccia C, Marampon F, Gravina GL, Ventura L, Di Cesare E, Cicchinelli S, Gaudio E, Vetuschi A. 2017. The possible prognostic role of histone deacetylase and transforming growth factor beta/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study. Eur J Histochem. 61(2):2732. doi:10.4081/ejh.2017.2732.
   PubMed Web of Science ®Google Scholar
• Mao J, Sun Z, Cui Y, Du N, Guo H, Wei J, Hao Z, Zheng L. 2020. PCBP2 promotes the development of glioma by regulating FHL3/TGF-beta/Smad signaling pathway. J Cell Physiol. 235(4):3280–3291. doi:10.1002/jcp.29104.
   PubMed Web of Science ®Google Scholar
• Jin H, Luo C. Bleomycin inhibits proliferation and promotes apoptosis of brain glioma cells via TGF-beta/Smad signaling pathway. J BUON. 2020;25(2):1076–1083.
   PubMed Web of Science ®Google Scholar
• Li N, Zhang R. 2020. Silencing of p53 reduces cell migration in human Tenon’s fibroblasts induced by TGF-beta. Int Ophthalmol. 40(6):1509–1516. doi:10.1007/s10792-020-01320-9.
   PubMed Web of Science ®Google Scholar
• Yue Y, Li YQ, Fu S, Wu YT, Zhu L, Hua L, Lv JY, Li YL, Yang DL. 2020. Osthole inhibits cell proliferation by regulating the TGF-beta1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells. Biomed Pharmacother. 121:109640. doi:10.1016/j.biopha.2019.109640.
   PubMed Web of Science ®Google Scholar
• Wiener Z, Band AM, Kallio P, Hogstrom J, Hyvonen V, Kaijalainen S, Ritvos O, Haglund C, Kruuna O, Robine S, et al. 2014. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-beta. Proc Natl Acad Sci U S A. 111(21):E2229–2236. doi:10.1073/pnas.1406444111.
   PubMed Web of Science ®Google Scholar
• Al-Shabanah OA, Aleisa AM, Hafez MM, Al-Rejaie SS, Al-Yahya AA, Bakheet SA, Al-Harbi MM, Sayed-Ahmed MM. 2012. Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-beta/Smad p53 pathway in rat model. Oxid Med Cell Longev. 2012:619185. doi:10.1155/2012/619185.
   PubMed Web of Science ®Google Scholar